| Transport across the cell-membrane dictates nanoparticle fate and toxicity: a new paradigm in nanotoxicology D Guarnieri, S Sabella, O Muscetti, V Belli, MA Malvindi, S Fusco, ... Nanoscale 6 (17), 10264-10273, 2014 | 91 | 2014 |
| Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines PP Vitiello, C Cardone, G Martini, D Ciardiello, V Belli, N Matrone, G Barra, ... Journal of Experimental & Clinical Cancer Research 38, 1-12, 2019 | 75 | 2019 |
| EPHA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer G Martini, C Cardone, PP Vitiello, V Belli, S Napolitano, T Troiani, ... Molecular Cancer Therapeutics 18 (4), 845-855, 2019 | 71 | 2019 |
| Personality disorders in addiction outpatients: prevalence and effects on psychosocial functioning P Casadio, D Olivoni, B Ferrari, C Pintori, E Speranza, M Bosi, V Belli, ... Substance Abuse: Research and Treatment 8, SART. S13764, 2014 | 59 | 2014 |
| Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity D Guarnieri, MA Malvindi, V Belli, PP Pompa, P Netti Journal of nanoparticle research 16 (2), 2229, 2014 | 54 | 2014 |
| Dynamics of nanoparticle diffusion and uptake in three-dimensional cell cultures V Belli, D Guarnieri, M Biondi, F Della Sala, PA Netti Colloids and Surfaces B: Biointerfaces 149, 7-15, 2017 | 43 | 2017 |
| Sub-100 nm biodegradable nanoparticles: in vitro release features and toxicity testing in 2D and 3D cell cultures M Biondi, D Guarnieri, H Yu, V Belli, PA Netti Nanotechnology 24 (4), 045101, 2013 | 38 | 2013 |
| Metabolomic approach for a rapid identification of natural products with cytotoxic activity against human colorectal cancer cells V Graziani, M Scognamiglio, V Belli, A Esposito, B D’Abrosca, ... Scientific Reports 8 (1), 5309, 2018 | 37 | 2018 |
| Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer DOI: 10.18632/oncotarget.20054, 2017 | 37* | 2017 |
| Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR MF Della Corte CM, Malapelle U, Vigliar E, Pepe F, Troncone G, Ciaramella V ... Oncotarget. 2017 Apr 4;8(14):23020-23032. doi: 10.18632/oncotarget.15479., 2017 | 35* | 2017 |
| Tumor‐activated prodrug (TAP)‐conjugated nanoparticles with cleavable domains for safe doxorubicin delivery D Guarnieri, M Biondi, H Yu, V Belli, AP Falanga, M Cantisani, S Galdiero, ... Biotechnology and bioengineering 112 (3), 601-611, 2015 | 33 | 2015 |
| Multilayered silica-biopolymer nanocapsules with a hydrophobic core and a hydrophilic tunable shell thickness R Vecchione, G Luciani, V Calcagno, A Jakhmola, B Silvestri, D Guarnieri, ... Nanoscale 8 (16), 8798-8809, 2016 | 32 | 2016 |
| Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells F Morgillo, CM Della Corte, A Diana, C di Mauro, V Ciaramella, G Barra, ... Oncotarget 8 (44), 76479, 2017 | 31 | 2017 |
| AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer C Cardone, B Blauensteiner, V Moreno-Viedma, G Martini, V Simeon, ... European Journal of Cancer 138, 1-10, 2020 | 29 | 2020 |
| Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression S Napolitano, N Matrone, AL Muddassir, G Martini, A Sorokin, V De Falco, ... Journal of Experimental & Clinical Cancer Research 38, 1-18, 2019 | 29 | 2019 |
| Biocompatible nanoparticles sensing the matrix metallo-proteinase 2 for the on-demand release of anticancer drugs in 3D tumor spheroids M Cantisani, D Guarnieri, M Biondi, V Belli, M Profeta, L Raiola, PA Netti Colloids and Surfaces B: Biointerfaces 135, 707-716, 2015 | 22 | 2015 |
| Biostability enhancement of oil core—polysaccharide multilayer shell via photoinitiator free thiol-ene ‘click’reaction V Calcagno, R Vecchione, A Sagliano, A Carella, D Guarnieri, V Belli, ... Colloids and Surfaces B: Biointerfaces 142, 281-289, 2016 | 19 | 2016 |
| Bioinspired oil core/silica shell nanocarriers with tunable and multimodal functionalities A Jakhmola, R Vecchione, D Guarnieri, V Belli, D Calabria, PA Netti Advanced Healthcare Materials 4 (17), 2688-2698, 2015 | 19 | 2015 |
| Surface decoration with gH625-membranotropic peptides as a method to escape the endo-lysosomal compartment and reduce nanoparticle toxicity D Guarnieri, O Muscetti, A Falanga, S Fusco, V Belli, E Perillo, E Battista, ... Nanotechnology 26 (41), 415101, 2015 | 18 | 2015 |
| Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models V Belli, N Matrone, S Napolitano, G Migliardi, F Cottino, A Bertotti, ... Journal of Experimental & Clinical Cancer Research 38, 1-14, 2019 | 17 | 2019 |
